“…The majority of the physiological actions of the purine adenosine are antagonistic to the actions of ANG II such as the effects on blood pressure control where adenosine appears to be a potent vasodilator and ANG II -vasoconstrictor (Jackson et al, 1985). Furthermore, adenosine effectively blocks the release of renin, thus reducing plasma levels of the octapeptide (Jackson, 1991). On the other hand, ANG II and adenosine have a complex synergistic interaction on glomerular dynamics (Hall and Granger, 1986), adrenergic neurotransmission release (Trachte and Heller, 1990), and vasoconstrictor response regulation (Dietrich et al, 1991).…”